Bionano Genomics, Inc.
Price Action
Technical Summary
WEAKENINGBionano Genomics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 15), showing significant lag compared to the market leaders. Earnings growth of 100% provides fundamental context to the price action. Investors should exercise caution due to high volatility (82% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.22 | +4.01% | ABOVE |
| 50 SMA | $1.18 | +7.43% | ABOVE |
| 100 SMA | $1.30 | -2.47% | BELOW |
| 150 SMA | $1.46 | -13.10% | BELOW |
| 200 SMA | $1.88 | -32.34% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BNGO in an uptrend right now?
BNGO has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is BNGO overbought or oversold?
BNGO's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is BNGO outperforming the market?
BNGO has a Relative Strength (RS) Rating of 15 out of 99. BNGO is currently lagging the broader market.
Where is BNGO in its 52-week range?
BNGO is trading at $1.27, which is 23% of its 52-week high ($5.50) and 5% above its 52-week low ($1.06).
How volatile is BNGO?
BNGO has a Beta of 1.47 and 52-week volatility of 82%. It's more volatile than the S&P 500 - expect bigger swings.